Block O'Toole & Murphy
New York Personal Injury Lawyers
For a Free Consultation Call
212-736-5300 212-736-5300

September 2011 Archives

Block O'Toole & Murphy Welcomes New Attorney

Block O’Toole & Murphy is pleased to welcome Christina Mark as the newest attorney to join the firm. Christina had previously worked as a legal intern for the firm the previous summer, and was hired as an associate in September. She has served as an intern for the Honorable Joan O’Dwyer of the New York Supreme Court in Queens County, as well as an intern for the Nassau County District Attorney in the Appeals Bureau. Her exceptional skills and acumen for the profession, as well as an unparalleled work ethic, will serve the firm and its clients well for years to come.

Rochester Crane Collapse Results in Death of Operator

A Gerace Construction worker was killed when the crane he was operating tipped into a gorge and ensnared him, according to the Wall Street Journal. The victim, Douglas Fitzmaurice of Wolcott, was moving the crane from one side of the spillway to the other. Rescue crews attempted to lift 35 ton crane off the victim, who was still alive after the accident, but he later died from his injuries. Fitzmaurice was working on a Rochester Gas & Electric Corp. (RG&E) hydroelectric station project on the shore of the Genesee River in Monroe County.

Transvaginal Mesh Complications May Lead FDA to Classify Devices as High Risk

The FDA is proposing stricter regulations for transvaginal mesh products used in the repair of pelvic organ prolapse (POP), according to the Wall Street Journal. A document on the agency's website announced that the "rate and severity" of POP mesh complications in patients implanted transvaginally has called into question the safety of the products. Under the proposal, transvaginal meshes used in POP patients would be reclassified into Class III, the highest risk category available for medical devices. If the new mesh proposals are enacted, the devices would be subject to a premarket review process, which would mandate that manufacturers conduct research on the product's safety and effectiveness before being approved. Currently, transvaginal meshes, which have been linked to serious complications including mesh erosion and vaginal scarring, are reviewed under a fast-tracked 510(k) process in which products are approved based on their similarity to those already on the market.